A detailed history of Ae Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ae Wealth Management LLC holds 225,929 shares of ABBV stock, worth $40.3 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
225,929
Previous 255,671 11.63%
Holding current value
$40.3 Million
Previous $43.9 Million 1.74%
% of portfolio
0.46%
Previous 0.49%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $4.87 Million - $5.93 Million
-29,742 Reduced 11.63%
225,929 $44.6 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $8.3 Million - $9.69 Million
53,590 Added 26.52%
255,671 $43.9 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $20.7 Million - $23.6 Million
-129,442 Reduced 39.04%
202,081 $36.8 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $623,603 - $702,324
4,532 Added 1.39%
331,523 $51.4 Million
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $2.67 Million - $3.09 Million
19,986 Added 6.51%
326,991 $48.7 Million
Q2 2023

Jul 10, 2023

SELL
$132.51 - $164.9 $1.02 Million - $1.27 Million
-7,704 Reduced 2.45%
307,005 $41.4 Million
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $380,902 - $438,666
-2,634 Reduced 0.83%
314,709 $50.2 Million
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $1.76 Million - $2.11 Million
12,699 Added 4.17%
317,343 $51.3 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $5.73 Million - $6.57 Million
42,675 Added 16.29%
304,644 $40.9 Million
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $2.44 Million - $3.11 Million
-17,757 Reduced 6.35%
261,969 $40.1 Million
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $770,895 - $956,463
-5,841 Reduced 2.05%
279,726 $45.3 Million
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $4.43 Million - $5.61 Million
41,265 Added 16.89%
285,567 $38.7 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $798,638 - $906,574
7,506 Added 3.17%
244,302 $26.4 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $2.94 Million - $3.28 Million
27,943 Added 13.38%
236,796 $26.7 Million
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $1.06 Million - $1.17 Million
10,379 Added 5.23%
208,853 $22.6 Million
Q4 2020

Feb 01, 2021

BUY
$80.49 - $108.67 $1.15 Million - $1.55 Million
14,258 Added 7.74%
198,474 $21.3 Million
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $2.03 Million - $2.38 Million
-23,596 Reduced 11.35%
184,216 $16.1 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $4.33 Million - $5.8 Million
59,028 Added 39.67%
207,812 $20.4 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $794,898 - $1.21 Million
12,324 Added 9.03%
148,784 $11.3 Million
Q4 2019

Jan 15, 2020

BUY
$72.13 - $90.25 $2.29 Million - $2.86 Million
31,730 Added 30.3%
136,460 $12.1 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $1.02 Million - $1.22 Million
16,163 Added 18.25%
104,730 $7.93 Million
Q2 2019

Jul 22, 2019

BUY
$65.7 - $83.98 $3.29 Million - $4.21 Million
50,072 Added 130.07%
88,567 $6.44 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $455,511 - $536,114
5,905 Added 18.12%
38,495 $3.1 Million
Q4 2018

Feb 15, 2019

SELL
$77.85 - $96.01 $506,102 - $624,161
-6,501 Reduced 16.63%
32,590 $3.01 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $804,368 - $894,205
9,047 Added 30.11%
39,091 $3.7 Million
Q2 2018

Aug 15, 2018

BUY
$89.78 - $106.23 $681,609 - $806,498
7,592 Added 33.81%
30,044 $2.78 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $190,092 - $254,551
-2,066 Reduced 8.43%
22,452 $2.13 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $1.11 Million - $1.22 Million
-12,396 Reduced 33.58%
24,518 $2.37 Million
Q3 2017

Nov 08, 2017

SELL
$69.85 - $89.22 $603,364 - $770,682
-8,638 Reduced 18.96%
36,914 $3.28 Million
Q2 2017

Aug 14, 2017

BUY
N/A
45,552
45,552 $3.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.